Delivery Order SPE2DX22D0010-SPE2D826FAK48
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for MS Contin ER 30 mg tablets (100-count units) valued at $2,051.60. This firm fixed-price delivery order, which is not set-aside designated, represents a competitively awarded transaction under the company's existing indefinite delivery contract with DLA Troop Support Medical. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $8,192.71 to AmerisourceBergen Drug Corp on October 3, 2025, for the supply of Morphine Sulfate Continuous Release Tablets 30mg. The contract is firm fixed price with no set-aside designation and an ultimate completion date of October 6, 2025. AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, will serve as the place of performance. This delivery order is issued under the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $8,327.64 on August 7, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which serves as a child contract to a larger vehicle, is scheduled for ultimate completion on August 8, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,287.68 by the Defense Logistics Agency's Medical Supply Chain on July 26, 2025. This competitively awarded, firm fixed-price contract is classified as a child order and carries an ultimate completion date of July 28, 2025. The award represents a small-value transaction typical of the company's extensive federal medical procurement activities supporting military and veteran...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,635.46 on August 5, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, competitively awarded contract is scheduled for ultimate completion on August 6, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This delivery order represents a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,762.72 by the Defense Logistics Agency's Medical Supply Chain on September 30, 2025, with completion scheduled for October 1, 2025. This firm fixed-price delivery order, issued as a non-set-aside competitive award, represents a continuation of the company's role as a critical pharmaceutical and medical supply vendor supporting federal healthcare procurement needs. The work will be performed at the company's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,045.04 by the Defense Logistics Agency's Medical Supply Chain on August 17, 2025. This non-competitive delivery order represents a firm fixed price contract with an ultimate completion date of August 18, 2025, and is classified as a child contract under a larger indefinite delivery vehicle. The award demonstrates AmerisourceBergen's continued role...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $30,969 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. The delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $7,964 on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This is a firm fixed-price, non-set-aside delivery order issued under an existing contract vehicle, with an ultimate completion date of September 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As the awardee, AmerisourceBergen—a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,578.60 on August 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, designated as a non-competitive award without set-aside designation, is scheduled for completion by August 19, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAK48Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on October 16, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of MS Contin Tablets 30mg, a controlled-release morphine sulfate pain management pharmaceutical. This non-competitive delivery order, valued at $2,706.81 with firm fixed pricing, is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a standard transactional deployment under the company's existing federal contract vehicle for pharmaceutical procurement. This delivery order functions as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor serving federal military and veteran healthcare systems, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the Defense Logistics Agency, supplying specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. The delivery order award demonstrates the company's ongoing role as a critical vendor supporting Department of Defense medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/16/25 |